CNCCS is an Italian public-private consortium formed in 2010, between the Italian National Research Council (CNR), the Italian National Institute of Health (ISS) and IRBM, which operates in the field of translational medical research. CNR, ISS and IRBM are ideal associates in this project, each contributing unique and synergistic capabilities and experiences. The CNR and ISS are two of the principal centres of excellence in biomedical research in Italy.
The objective of the CNCCS Consortium is to create a central repository of organic compounds and to serve as a national and European high throughput screening hub for the identification of novel lead compounds acting on biological targets of interest. Compounds originating from public and private sources are collected and screened with the purpose of enabling and accelerating the translation of new basic research discoveries into the development of molecules to study gene function and biological mechanisms, and of novel medicines, in particular for Rare, Neglected and Poverty Related diseases. The CNCCS has already achieved key milestones towards its objectives: